Загрузка...
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric antigen receptor (CAR) T cells have shown unparalleled therapeutic potential in treating refractory hematological malignanci...
Сохранить в:
| Опубликовано в: : | Cells |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562702/ https://ncbi.nlm.nih.gov/pubmed/31108883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8050472 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|